Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF EXECUTIVE OFFICER

PRESIDENT AND CFO

CHIEF OPERATING OFFICER

SVP, GEN COUNSEL & CORP SEC

SVP, FINANCE

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against these emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious di...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-23	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-23	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-18	Premium	acquired	Premium	Premium	Premium	PRESIDENT AND CFO
2024-04-18	Premium	sold	Premium	Premium	Premium	PRESIDENT AND CFO
2024-04-17	Premium	acquired	Premium	Premium	Premium	CHIEF OPERATING OFFICER
2024-04-01	Premium	sold	Premium	Premium	Premium	CHIEF OPERATING OFFICER
2024-04-01	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-01	Premium	sold	Premium	Premium	Premium	SVP, GEN COUNSEL & CORP SEC
2024-04-01	Premium	acquired	Premium	Premium	Premium	SVP, GEN COUNSEL & CORP SEC
2024-03-25	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-03-25	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-03-18	Premium	sold	Premium	Premium	Premium	PRESIDENT AND CFO
2024-03-18	Premium	acquired	Premium	Premium	Premium	PRESIDENT AND CFO
2024-03-15	Premium	acquired	Premium	Premium	Premium	CHIEF OPERATING OFFICER
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF OPERATING OFFICER
2024-03-11	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-03-02	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-03-02	Premium	sold (taxes)	Premium	Premium	Premium	SVP, GEN COUNSEL & CORP SEC
2024-03-02	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF OPERATING OFFICER
2024-03-02	Premium	sold (taxes)	Premium	Premium	Premium	PRESIDENT AND CFO
2024-03-02	Premium	sold (taxes)	Premium	Premium	Premium	SVP, FINANCE
2024-03-01	Premium	acquired	Premium	Premium	Premium	SVP, FINANCE
2024-03-01	Premium	sold	Premium	Premium	Premium	CHIEF OPERATING OFFICER
2024-03-01	Premium	acquired	Premium	Premium	Premium	SVP, GEN COUNSEL & CORP SEC
2024-03-01	Premium	sold	Premium	Premium	Premium	SVP, GEN COUNSEL & CORP SEC

PCVX - Vaxcyte, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for PCVX